Russell Investments Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Russell Investments Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-300	Closed	-$4K	–	3034
2019 Q1	$4K	Buy	+300	New	+$3.89K	﹤0.01%	2900
2018 Q4	–	Sell	-2,200	Closed	-$37K	–	3098
2018 Q3	$37K	Sell	2,200 -200	-8%	-$3.62K	﹤0.01%	2863
2018 Q2	$38K	Buy	+2,400	New	+$36.5K	﹤0.01%	2840
2018 Q1	–	Sell	-2,500	Closed	-$29K	–	3067
2017 Q4	$29K	Buy	+2,500	New	+$27.9K	﹤0.01%	2912
2017 Q3	–	Sell	-42,416	Closed	-$486K	–	3052
2017 Q2	$486K	Buy	42,416 +2,837	+7%	+$52.5K	﹤0.01%	2423
2017 Q1	$823K	Buy	39,579 +23,437	+145%	+$519K	﹤0.01%	2206
2016 Q4	$334K	Buy	+16,142	New	+$420K	﹤0.01%	2588

Other funds holding ALDR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Russell Investments Group's ALDR Position: Q2 2019 in Review

Russell Investments Group sold out of Alder Biopharmaceuticals (ALDR) in Q2 2019, closing a stake of 300 shares — an estimated $4K sold.

Russell Investments Group first reported a position in ALDR in Q4 2016 and held it in 7 quarters. The position peaked at $823K in Q1 2017. 127 funds tracked by Wall St. Rank hold ALDR as of Q2 2019.

Russell Investments Group reported no remaining Alder Biopharmaceuticals position as of Q2 2019 after selling out during the quarter.
Russell Investments Group sold 300 Alder Biopharmaceuticals shares in Q2 2019, an estimated $4K.
Russell Investments Group first reported a position in Alder Biopharmaceuticals in Q4 2016 and held it in 7 quarters.
Russell Investments Group's Alder Biopharmaceuticals position peaked at $823K in Q1 2017.
127 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2019.

Based on Russell Investments Group's 13F filing for Q2 2019, filed 9 Aug 2019.